195
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Efficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells

, , &
Pages 237-239 | Received 24 May 2019, Accepted 18 Aug 2019, Published online: 10 Sep 2019
 

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by a High-Tech Research Center Project for Private Universities, a matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and by the University-Industry Joint Research Project for Private Universities, a matching fund subsidy from MEXT. This work was also supported by Grants-in-Aid for Scientific Research from MEXT.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.